DD3 Acquisition Corp. II (DDMXU)
Price:
10.10 USD
( - -0.15 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Churchill Capital Corp X
VALUE SCORE:
7
2nd position
Range Capital Acquisition Corp.
VALUE SCORE:
10
The best
M3-Brigade Acquisition V Corp. Units
VALUE SCORE:
10
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
NEWS
DD3 Acquisition Corp. II Receives Expected Notice from Nasdaq Regarding Delayed Quarterly Report
globenewswire.com
2021-06-03 16:15:00MEXICO CITY, June 03, 2021 (GLOBE NEWSWIRE) -- DD3 Acquisition Corp. II (Nasdaq: DDMX) (the “Company”) today announced that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”) due to a delay in filing its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”). The Notice has no immediate effect on the listing or trading of the Company's securities on the Nasdaq Capital Market.
DD3 Acquisition Corp. II Announces the Separate Trading of Its Class A Common Stock and Warrants Commencing on or About January 27, 2021
globenewswire.com
2021-01-26 16:10:00MEXICO CITY, Jan. 26, 2021 (GLOBE NEWSWIRE) -- DD3 Acquisition Corp. II (the “Company”), today announced that holders of the units sold in the Company's initial public offering of 12,500,000 units completed on December 10, 2020 (the “offering”) may elect to separately trade the shares of Class A common stock and warrants included in the units commencing on or about January 27, 2021. Any units not separated will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol “DDMXU,” and each of the shares of Class A common stock and warrants will separately trade on Nasdaq under the symbols “DDMX” and “DDMXW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into shares of Class A common stock and warrants.
U.S. IPO Weekly Recap: Breast Cancer Biotech Pops 158% In A 6-IPO Week
seekingalpha.com
2020-11-22 13:07:23In a scramble to go public ahead of the holiday, six IPOs and 15 SPACs went public this past week led by breast cancer biotech Olema Pharmaceuticals, which soared 158% on its first day. New filings continued to pour in, priming the IPO pipeline for an active end to 2020.
No data to display
DD3 Acquisition Corp. II Receives Expected Notice from Nasdaq Regarding Delayed Quarterly Report
globenewswire.com
2021-06-03 16:15:00MEXICO CITY, June 03, 2021 (GLOBE NEWSWIRE) -- DD3 Acquisition Corp. II (Nasdaq: DDMX) (the “Company”) today announced that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”) due to a delay in filing its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”). The Notice has no immediate effect on the listing or trading of the Company's securities on the Nasdaq Capital Market.
DD3 Acquisition Corp. II Announces the Separate Trading of Its Class A Common Stock and Warrants Commencing on or About January 27, 2021
globenewswire.com
2021-01-26 16:10:00MEXICO CITY, Jan. 26, 2021 (GLOBE NEWSWIRE) -- DD3 Acquisition Corp. II (the “Company”), today announced that holders of the units sold in the Company's initial public offering of 12,500,000 units completed on December 10, 2020 (the “offering”) may elect to separately trade the shares of Class A common stock and warrants included in the units commencing on or about January 27, 2021. Any units not separated will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol “DDMXU,” and each of the shares of Class A common stock and warrants will separately trade on Nasdaq under the symbols “DDMX” and “DDMXW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into shares of Class A common stock and warrants.
U.S. IPO Weekly Recap: Breast Cancer Biotech Pops 158% In A 6-IPO Week
seekingalpha.com
2020-11-22 13:07:23In a scramble to go public ahead of the holiday, six IPOs and 15 SPACs went public this past week led by breast cancer biotech Olema Pharmaceuticals, which soared 158% on its first day. New filings continued to pour in, priming the IPO pipeline for an active end to 2020.